Related Experiment Videos
Summary
Immunopharmacology has advanced significantly, offering targeted therapies like monoclonal antibodies and gene therapy for immune disorders. These innovations complement traditional immunosuppressants for autoimmune diseases and transplant rejection.
Area of Science:
- Immunopharmacology
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Traditional immunosuppressive drugs are used for autoimmune diseases and transplant rejection.
- Advances in cell biology and antibody technology enable targeted therapies.
- New agents are emerging to enhance immune responses and correct deficits.
Purpose of the Study:
- To review the dramatic changes in immunopharmacology over the past 25 years.
- To highlight advancements in targeted therapies beyond traditional immunosuppression.
- To discuss emerging strategies for immune enhancement and correction.
Main Methods:
- Review of traditional immunosuppressive drug therapies.
- Engineering of specific monoclonal antibodies targeting immune cells or mediators.
- Development of growth factor, cytokine, and gene therapies.
Main Results:
- Highly specific antibodies can be engineered for targeted immune cell or tumor treatment.
- Novel agents and methods enhance immune responses and correct immune deficits.
- Gene therapy offers a potential long-term treatment for genetic immune disorders.
Conclusions:
- Immunopharmacology has evolved with targeted therapies like monoclonal antibodies.
- Advances include immune-enhancing strategies and gene therapy for immune disorders.
- Many novel immunopharmacological approaches are in early stages of investigation.